ASH Coverage: Hodgkin and Non-Hodgkin Lymphoma Research and Treatment News

During the 2014 American Society of Hematology (ASH) annual meeting, Dr. Ajay Gopal from Seattle Cancer Care Alliance joined Patient Power to share exciting treatment news for lymphomas. He provided an overview of all the latest, including positive news about the oral therapy Zydelig® (idelalisib) in non-Hodgkin lymphoma, a trial in progress for brentuximab vedotin (Adcetris) for refractory Hodgkin lymphoma, and much more in research and clinical trials in progress for myeloma.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo